Search

Search Results
Results 171 - 180 of 183 for Adrenal
  • DBL Sodium Phosphate and Potassium Phosphate
    Drug - 30 Jan 2023
    Consumer Medicine Information (CMI) about DBL Sodium Phosphate and Potassium Phosphate intended for persons living in Australia.
  • DBL Potassium Acetate Concentrated Injection
    Drug - 30 Jan 2023
    Consumer Medicine Information (CMI) about DBL Potassium Acetate Concentrated Injection intended for persons living in Australia.
  • Reaptan
    Drug - 2 Aug 2022
    Consumer Medicine Information (CMI) about Reaptan (Perindopril/amlodipine [pronounced per-in-do-pril/ am-load-i-peen]) intended for persons living in Australia.
  • Diamicron 60mg MR
    Drug - 18 Jul 2022
    Consumer Medicine Information (CMI) about Diamicron 60mg MR (containing gliclazide) intended for persons living in Australia.
  • Ardix Gliclazide 60mg MR
    Drug - 18 Jul 2022
    Consumer Medicine Information (CMI) about Ardix Gliclazide 60mg MR (containing gliclazide) intended for persons living in Australia.
  • Samsca
    Drug - 30 Jun 2022
    Consumer Medicine Information (CMI) about Samsca intended for persons living in Australia.
  • Ovaleap
    Drug - 23 May 2022
    Consumer Medicine Information (CMI) about Ovaleap intended for persons living in Australia.
  • Aurorix
    Drug - 21 Mar 2022
    Consumer Medicine Information (CMI) about Aurorix intended for persons living in Australia.
  • Amira 150 and Amira 300
    Drug - 21 Mar 2022
    Consumer Medicine Information (CMI) about Amira 150 and Amira 300 intended for persons living in Australia.
  • Lorviqua
    Drug - 23 Dec 2021
    Consumer Medicine Information (CMI) about Lorviqua intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback